These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20200327)

  • 21. Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury.
    Seubert JM; Zeldin DC; Nithipatikom K; Gross GJ
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):50-9. PubMed ID: 17164132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The roles of eicosanoids in myocardial diseases.
    He Z; Wang DW
    Adv Pharmacol; 2023; 97():167-200. PubMed ID: 37236758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The roles of cytochrome p450 in ischemic heart disease.
    Sato M; Yokoyama U; Fujita T; Okumura S; Ishikawa Y
    Curr Drug Metab; 2011 Jul; 12(6):526-32. PubMed ID: 21476972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P-450 metabolism of arachidonic acid.
    McGiff JC
    Annu Rev Pharmacol Toxicol; 1991; 31():339-69. PubMed ID: 1905908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epoxygenase metabolites. Epithelial and vascular actions.
    Imig JD
    Mol Biotechnol; 2000 Nov; 16(3):233-51. PubMed ID: 11252808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beating ischemia: a new feat of EETs?
    Bhatnagar A
    Circ Res; 2004 Sep; 95(5):443-5. PubMed ID: 15345665
    [No Abstract]   [Full Text] [Related]  

  • 27. Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury.
    Ross S; Foëx P
    Br J Anaesth; 1999 Apr; 82(4):622-32. PubMed ID: 10472233
    [No Abstract]   [Full Text] [Related]  

  • 28. Cytochrome P450: major player in reperfusion injury.
    Gottlieb RA
    Arch Biochem Biophys; 2003 Dec; 420(2):262-7. PubMed ID: 14654065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel prosurvival model for cancer under environmental challenge: the "heart-felt" message for therapeutic intervention.
    Loudon JA
    Oncol Res; 2011; 19(8-9):407-43. PubMed ID: 22329201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Diaryl-1,2,4-triazolo[3,4-
    Al-Wahaibi LH; Abdel-Rahman MH; El-Adl K; Youssif BGM; Bräse S; Abdel-Aziz SA
    ACS Omega; 2024 Aug; 9(31):33494-33509. PubMed ID: 39130606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble Epoxide Hydrolase Inhibitors Regulate Ischemic Arrhythmia by Targeting MicroRNA-1.
    Chen Y; Liu Q; Yang T; Shen L; Xu D
    Front Physiol; 2021; 12():717119. PubMed ID: 34646152
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro aged, hiPSC-origin engineered heart tissue models with age-dependent functional deterioration to study myocardial infarction.
    Acun A; Nguyen TD; Zorlutuna P
    Acta Biomater; 2019 Aug; 94():372-391. PubMed ID: 31146032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome.
    Oni-Orisan A; Cresci S; Jones PG; Theken KN; Spertus JA; Lee CR
    Prostaglandins Other Lipid Mediat; 2018 Sep; 138():15-22. PubMed ID: 30096423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics.
    Imig JD
    Pharmacol Ther; 2018 Dec; 192():1-19. PubMed ID: 29964123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.
    Edin ML; Hamedani BG; Gruzdev A; Graves JP; Lih FB; Arbes SJ; Singh R; Orjuela Leon AC; Bradbury JA; DeGraff LM; Hoopes SL; Arand M; Zeldin DC
    J Biol Chem; 2018 Mar; 293(9):3281-3292. PubMed ID: 29298899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders.
    Lakkappa N; Krishnamurthy PT; Hammock BD; Velmurugan D; Bharath MM
    Med Hypotheses; 2016 Aug; 93():161-5. PubMed ID: 27372879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of Metastatic Tumor Dormancy.
    Osisami M; Keller ET
    J Clin Med; 2013 Sep; 2(3):136-50. PubMed ID: 26237067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism.
    Spector AA; Kim HY
    Biochim Biophys Acta; 2015 Apr; 1851(4):356-65. PubMed ID: 25093613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epoxyeicosatrienoic acids and cardioprotection: the road to translation.
    Oni-Orisan A; Alsaleh N; Lee CR; Seubert JM
    J Mol Cell Cardiol; 2014 Sep; 74():199-208. PubMed ID: 24893205
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.